Transformational Therapeutics for Serious Diseases
Scopus BioPharma is a biopharmaceutical company developing transformational therapeutics targeting serious diseases with significant unmet medical needs. The companys lead development program, CO-sTiRNA, is a novel targeted immuno-oncology gene therapy for the treatment of multiple cancers. Its second lead development program, MRI-1867, is a peripherally re…